Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
$RDGL - Awesome news!
Another horse has been helped with IsoPet® Precision Radionuclide Therapy™ for caudal heel pain. This is very exciting news for many horse owners and is now another use for IsoPet® therapy. #IsoPet #RadioGel #VivosIncUSA #CaudalHeelPain $RDGL pic.twitter.com/ida9JC6kOh
— IsoPet® Cancer Treatment (@IsoPetForCancer) February 29, 2024
Korenko and BOD collectively decided to develop the IsoPet side while pursuing IDE approval. Very smart and astute decision. IsoPet will be years ahead when IDE approval happens, and so will profits! Smart investors know this.
My typical advice is always protect your capital investment and don’t over leverage. How ever, this is one of the few exceptions to the rule. With the path Vivos is on with FDA, my hold position through IDE approval has increased exponentially lol.
Yup! Skim some profits on submission and hold majority for IDE approval, which imo is turning into a 99.9% sure thing.
Never seen some repeatedly and intentionally give incorrect and misleading information. A village somewhere is missing their idiot.
Certification is not a requirement for IDE approval. But based on the update about Mayo Team completing initial training and will complete final certification training “this year”, it will be required before the start of clinical trials.
I think their update speaks for itself. Mayo Team who’s going to conduct the trials went the initial certification training.
And final certification training to be completed “…This year.” Pretty much tells me they won’t complete certification until they get IDE approval and won’t start initial trial until completion of certification. Makes good sense. Don’t put the cart before the horse.
Treating cancer in humans means regular and extensive training sessions, it's part of the process that we wanted to share! #Cancer #lymph #training #VivosIncUSA #RadioGel #IsoPet #CancerTreatment #MayoClinic #PartOfTheProcess $RDGL pic.twitter.com/9E58okfqer
— Vivos Inc. (@VivosIncUSA) February 27, 2024
All I’m saying is if the vet clinics and staff who would be present during procedure are required to do certification, then Mayo IRB most likely requires it as well.
I’m pretty sure it’s due to the radioactive materials being used.
I believe it is, which is why they said the Mayo Clinic Team had started certification training and completion would be this year.
Final certification won’t happen until after IDE approval.
Excellent assessment and I agree. I also think the addition of the marketing team and new financial team speaks volumes for those who choose to listen. Vivos is very smart to muse their time to develop and promote Isopet while advancing closer to IDE approval.
Ultrasound is used as an imaging tool for the lymph node.
Like a petulant spiteful Karen. It is what it is.
I think it’s proprietary to E-Trade. Same as TOS with TDAmeritrade (Schwab).
There’s several of us who hold very sizable positions with a good cost average. Don’t call it lucky. I call it intelligent application of DD.
I wouldn’t be surprised to see offer interest after success of phase 1 human trials. And as I understand, with BDD, they should be able to accelerate and complete phase 1 much sooner. And would expect they start phase 1 within 2-3 months after IDE approval.
Got your PM. Check your email.
Ya. I get the play on Sullivan with “Sullitions” but I’d gone with Solutions also.
Doesn’t take much brains to connect dots to realize with Vivos recently adding a marketing team and now a financial management team, they are very confident in getting IDE approval and are getting things in place to start clinical trials, expansion of IsoPet, uplist to NASDAQ and then market approval for human use after successful clinical trials. $RDGL is one of the few OTC plays where substantial reward far outweighs the risk. Great opportunity to continue to add more shares.
Like a crazy ex. May be time to file a restraining order lol.
Excellent. I’ve added a few more too.
And with this post on X today, tells me Vivos is planning for more activity, growth etc., coming after IDE approval.
We believe in the financial health of our company and have taken steps to ensure our longevity as we continue to grow our brands! We welcome working with Sullivan Sullutions in 2024! #VivosInc #IsoPet #RadioGel #NextGenerationCancerTherapy $RDGL pic.twitter.com/qLOiSgzqJi
— Vivos Inc. (@VivosIncUSA) February 16, 2024
Serious issues. Probably one of several reasons he’s no longer an employee.
Given the last update when Cusip/ticker name change denied, no one still has answered what happens to GDVM if Melvin can’t resolve issues. Don’t see Melvin hanging on to GDVM if he can’t get it changed to his company.
Yup! Down to the last few items before completion and ready for submission. Good times coming!
Expecting the next major update early March to give a better submission timeline.
Actually agree. One of the main reasons most have left and avoid posting here.
May have many cards the game but still didn’t answer the question. They denied for various reasons. What happens if Melvin can’t satisfactorily resolve the issues for denial?
Still curious to know what happens to this ticker GDVM if Melvin is unable to resolve issue to get symbol/name change? Does he abandon this shell and on and try another?
Ya, pretty much why this board and IHub in general should only be used for entertainment purposes. Anyone using information from IHub board to make their investment decisions, shouldn’t be investing.
49ers for the win. Then Taylor Swift can dump Kelce and end that charade lol.
lol. “I personally won't be doing it, but it will be nice if some other people would.”
Spoken like a true politician. SMH.
Whatever you’re smoking, might want to take a breather. Company won’t do a buy back. Poor use of finances.
Driving his Lambo in the Cayman Islands enjoying the good life. License plate says “THNKSMLVN”.
Pretty simple. IDE will be approved. Vivos team has been on the FDA gateway path to ensure approval. So why not develop and further advance IsoPet? Company will be that much further ahead doing so. Under your method, once IDE is approved before starting IsoPet, Vivos would be several months, if not years, behind in development of IsoPet, clinics, and generating profit from IsoPet. Huge swing and miss there.
Put the FUDster on ignore like everyone else. He’s a paid per negative post/reply and disgraced ex employee.
The Vivos Marketing Team is getting things fired up!
It was a busy day working on our new website https://t.co/kXIvdr5CSv and marketing our Precision Radionuclide Therapy™ (PRnT) to clinics across the USA! Stay tuned for some blog posts soon! #isopet #cancer #radiogel #vivosinc #PRnT $RDGL pic.twitter.com/0kRGdQ6WNz
— IsoPet® Cancer Treatment (@IsoPetForCancer) February 8, 2024
Shows a lot of confidence they will get IDE approval and are planning accordingly.
To treat solid tumors safely, and more effectively, by Precision Radionuclide Therapy™ (PRnT) we need to have these beauties in production and we are moving ahead for Q2 & Q3! #vivosinc #cancertherapy #radiogel #isopet #nextgeneration #PRnt #Y90 $RDGL pic.twitter.com/MWhpWC31Wn
— Vivos Inc. (@VivosIncUSA) February 6, 2024
Given your future predicting abilities, you should be a billionaire by now smh.